Patents Assigned to Falcon Genomics, Inc.
  • High Throughput Assay for Cancer Cell Growth Inhibition
    Publication number: 20120077698
    Abstract: A high-throughput, anchorage-independent assay is described, which screens compounds for inhibition of cancer cell growth. The assay utilizes a three-dimensional matrix or semi-solid media transfected with the subject compound, and enables live colony growth determination and imaging.
    Type: Application
    Filed: November 9, 2011
    Publication date: March 29, 2012
    Applicant: Falcon Genomics, Inc.
    Inventor: Rula Abbud-Antaki
  • High throughput assay for cancer cell growth inhibition
    Patent number: 8110375
    Abstract: A high-throughput, anchorage-independent assay is described, which screens compounds for inhibition of cancer cell growth. The assay utilizes a three-dimensional matrix or semi-solid media transfected with the subject compound, and enables live colony growth determination and imaging.
    Type: Grant
    Filed: July 2, 2007
    Date of Patent: February 7, 2012
    Assignee: Falcon Genomics, Inc.
    Inventor: Rula Abbud-Antaki
  • High throughput assay for cancer cell growth inhibition
    Patent number: 7537913
    Abstract: A high-throughput, anchorage-independent assay is described, which screens compounds for inhibition of cancer cell growth. The assay utilizes a three-dimensional matrix or semi-solid media transfected with the subject compound, and enables live colony growth determination and imaging.
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: May 26, 2009
    Assignee: Falcon Genomics, Inc.
    Inventor: Rula Abbud-Antaki